Related Experiment Video

Updated: May 13, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Trends in hospitalizations among children with type 1 diabetes in Spain, 2001-2009

Ana López-de-Andrés1, Rodrigo Jiménez-García, Valentin Hernández-Barrera

  • 1Unidad de Docencia e Investigacion en Medicina Preventiva y Salud Publica, Madrid, Espana. ana.lopez@urjc.es

Journal of Pediatric Endocrinology & Metabolism : JPEM
|March 5, 2013
PubMed

Insights

Hospitalizations for type 1 diabetes in young children (0-4 years) in Spain increased from 2001-2009. However, overall discharge rates for children aged 0-14 years remained stable, suggesting effective outpatient management for older children.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Type 1 diabetes incidence is rising globally.
  • Understanding hospitalization trends is crucial for resource allocation and public health strategies.
  • Spain's national hospital discharge data provides a valuable resource for epidemiological studies.

Purpose of the Study:

  • To analyze trends in hospital discharges for pediatric type 1 diabetes in Spain between 2001 and 2009.
  • To identify specific age groups within the 0-14 years demographic experiencing changes in hospitalization rates.
  • To correlate hospitalization trends with the overall incidence of type 1 diabetes in Spain.

Main Methods:

  • Utilized national hospital discharge data from Spain.
  • Identified all discharges with a type 1 diabetes diagnosis.
  • Analyzed discharge incidence rates per 100,000 inhabitants for children aged 0-14 years.

Main Results:

  • A total of 22,955 hospital discharges for type 1 diabetes were recorded.
  • Overall discharge incidence per year slightly increased from 39.6 to 40.02 per 100,000 inhabitants.
  • Hospital discharge rates for children aged 0-14 years showed no significant change, but a significant increase was observed in the 0-4 years group (IRR 1.031).

Conclusions:

  • Hospitalization trends for type 1 diabetes in children aged 0-4 years in Spain have increased.
  • This increase aligns with the rising incidence of type 1 diabetes in the Spanish pediatric population.
  • Stable hospitalization rates in older children (10-14 years) may reflect successful outpatient management strategies.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...